254 related articles for article (PubMed ID: 34821653)
1. Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.
Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821653
[TBL] [Abstract][Full Text] [Related]
2. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
[TBL] [Abstract][Full Text] [Related]
3. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.
Daulton E; Wicaksono AN; Tiele A; Kocher HM; Debernardi S; Crnogorac-Jurcevic T; Covington JA
Talanta; 2021 Jan; 221():121604. PubMed ID: 33076134
[TBL] [Abstract][Full Text] [Related]
4. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
[TBL] [Abstract][Full Text] [Related]
5. Application of gas chromatography-ion mobility spectrometry (GC-IMS) and ultrafast gas chromatography electronic-nose (uf-GC E-nose) to distinguish four Chinese freshwater fishes at both raw and cooked status.
Chen YP; Cai D; Li W; Blank I; Liu Y
J Food Biochem; 2022 Jun; 46(6):e13840. PubMed ID: 34189733
[TBL] [Abstract][Full Text] [Related]
6. Non-Invasive Detection and Staging of Colorectal Cancer Using a Portable Electronic Nose.
Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
Sensors (Basel); 2021 Aug; 21(16):. PubMed ID: 34450881
[TBL] [Abstract][Full Text] [Related]
7. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
8. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer.
Guest C; Harris R; Sfanos KS; Shrestha E; Partin AW; Trock B; Mangold L; Bader R; Kozak A; Mclean S; Simons J; Soule H; Johnson T; Lee WY; Gao Q; Aziz S; Stathatou PM; Thaler S; Foster S; Mershin A
PLoS One; 2021; 16(2):e0245530. PubMed ID: 33596212
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds for early detection of prostate cancer from urine.
Liu Q; Fan Y; Zeng S; Zhao Y; Yu L; Zhao L; Gao J; Zhang X; Zhang Y
Heliyon; 2023 Jun; 9(6):e16686. PubMed ID: 37303549
[TBL] [Abstract][Full Text] [Related]
11. Identification of urinary volatile organic compounds as a potential non-invasive biomarker for esophageal cancer.
Liu Q; Li S; Li Y; Yu L; Zhao Y; Wu Z; Fan Y; Li X; Wang Y; Zhang X; Zhang Y
Sci Rep; 2023 Oct; 13(1):18587. PubMed ID: 37903959
[TBL] [Abstract][Full Text] [Related]
12. Furan and p-xylene as candidate biomarkers for prostate cancer.
Jiménez-Pacheco A; Salinero-Bachiller M; Iribar MC; López-Luque A; Miján-Ortiz JL; Peinado JM
Urol Oncol; 2018 May; 36(5):243.e21-243.e27. PubMed ID: 29395956
[TBL] [Abstract][Full Text] [Related]
13. Characteristic volatiles analysis of Dongbei Suancai across different fermentation stages based on HS-GC-IMS with PCA.
Han Y; Wang C; Zhang X; Li X; Gao Y
J Food Sci; 2022 Feb; 87(2):612-622. PubMed ID: 35067929
[TBL] [Abstract][Full Text] [Related]
14. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
Jacyna J; Wawrzyniak R; Balayssac S; Gilard V; Malet-Martino M; Sawicka A; Kordalewska M; Nowicki Ł; Kurek E; Bulska E; Patejko M; Markuszewski M; Gutknecht P; Matuszewski M; Siebert J; Kaliszan R; Markuszewski MJ
Talanta; 2019 Sep; 202():572-579. PubMed ID: 31171223
[TBL] [Abstract][Full Text] [Related]
16. Analysis of VOCs in Urine Samples Directed towards of Bladder Cancer Detection.
Ligor T; Adamczyk P; Kowalkowski T; Ratiu IA; Wenda-Piesik A; Buszewski B
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956972
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the volatile organic compounds produced from avocado during ripening by gas chromatography ion mobility spectrometry.
Liu Y; Bu M; Gong X; He J; Zhan Y
J Sci Food Agric; 2021 Jan; 101(2):666-672. PubMed ID: 32696460
[TBL] [Abstract][Full Text] [Related]
18. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
19. New findings on urinary prostate cancer metabolome through combined GC-MS and
Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
[TBL] [Abstract][Full Text] [Related]
20. Gas-phase volatilomic approaches for quality control of brewing hops based on simultaneous GC-MS-IMS and machine learning.
Brendel R; Schwolow S; Rohn S; Weller P
Anal Bioanal Chem; 2020 Oct; 412(26):7085-7097. PubMed ID: 32754792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
